| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.5M | — | -4.2% |
| Cost of Revenue | $6.5M | — | -4.6% |
| Gross Profit | $5.0M | — | -3.6% |
| R&D Expense | $2.2M | — | -10.0% |
| SG&A Expense | $2.5M | — | -23.9% |
| Operating Income | -$2.1M | — | +31.8% |
| Pre-tax Income | -$1.8M | — | -19.9% |
| Income Tax | $72K | — | +200.0% |
| Net Income | -$1.9M | — | -22.7% |
| EPS (Basic) | -$0.15 | — | -15.4% |
| EPS (Diluted) | -$0.15 | — | -15.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.1M | -3.1% | -3.7% |
| Accounts Receivable | $11.3M | -11.8% | -0.9% |
| Inventory | $4.1M | +13.6% | +8.3% |
| Current Assets | $23.8M | -7.4% | -0.8% |
| Total Assets | $43.4M | -4.3% | -5.9% |
| Current Liabilities | $11.5M | -11.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$759K | — | +26.0% |
| Capital Expenditures | $55K | — | +31.0% |
| Investing Cash Flow | -$143K | — | -240.5% |
| Financing Cash Flow | $722K | — | +1779.1% |
| Free Cash Flow | -$814K | — | +23.7% |
| +1.0% |
| Total Liabilities | $15.4M | -9.8% | -2.6% |
| Stockholders' Equity | $28.0M | -1.0% | -7.6% |